Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2)
US6316183A · kind A · utility
27Cited by
2References
6Claims
0Family size
Inventors
Key dates
| Filing date | Jun 6, 1995 |
| Grant date | Nov 13, 2001 |
| Priority date | — |
| Expiry date | Jun 6, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/974
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for diagnosing an HIV-2 (LAV-II) infection and a kit containing reagents for the same is disclosed. These reagents include cDNA probes which are capable of hybridizing to at least a portion of the genome of HIV-2. In one embodiment, the DNA probes are capable of hybridizing to the entire genome of HIV-2. These reagents also include polypeptides encoded by some of these DNA sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.